Home/News/Details

South Korea Seeks Comments on the Revision of Guidelines for Submission of Reports for Review-Exempt Functional Cosmetics

Oct 26, 2026
Korea
Favorites
Share
Unlock exclusive content and benefits? Sign up for free today!

On October 22, 2026, South Korea Cosmetic Industry Association (KCIA) released that the National Institute of Food and Drug Safety Evaluation (NIFDS) under the Ministry of Food and Drug Safety is seeking comments on the draft revision of the Guidelines for Submission of Reports for Review-Exempt Functional Cosmetics, with a comment deadline of October 27, 2026. Comments may be submitted to KCIA by email (ancho12@kcia.or.kr).

CIRS Group has now summarized the main contents of the draft revision as follows for reference.

Background and Legal Basis

Functional cosmetics are a core category in South Korea's regulation of cosmetic efficacy claims. Under South Korea's Cosmetics Act, functional cosmetics shall in principle undergo functional cosmetics review; those falling under the circumstances specified in Article 10 of the Enforcement Rule of the Cosmetics Act may be exempted from review and directly submit a functional cosmetics report to NIFDS. To guide the relevant responsible cosmetics sellers and cosmetic manufacturers in correctly fulfilling their reporting obligations, NIFDS developed the relevant guidelines on November 29, 2022.

This draft revision mainly adds an explanation of the circumstances under which requirements confirmation is not approved, and supplements the reporting method for customized cosmetics.

Under Article 10 of the Enforcement Rule of the Cosmetics Act, the functional cosmetics that may be exempted from review and managed through report submission include the following three categories:

  • Item No. 1: Functional cosmetics whose types and contents of functional ingredients, functions, methods of use and dosages, standards, and test methods are all identical to the items publicly notified by the Minister of Food and Drug Safety, such as the items listed in the Standards and Test Methods for Functional Cosmetics (KFCC) (e.g., niacinamide lotions, liquids, solid preparations, etc.);
  • Item No. 2: Items identical in all requirements to a reviewed functional cosmetic (limited to cases involving the same manufacturer — only where manufactured in the manufacturer design, development, and production mode (i.e., ODM), or the same responsible cosmetics seller, or the same research institution that has undergone review under Article 9 (1) of the Cosmetics Act, etc.). The requirements that must be identical include: types, specifications, and contents of functional ingredients; functions (for sun protection products, measurement values of the UV protection index within −20% are regarded as the same function); standards (except pH-related standards) and test methods; methods of use and dosages; and dosage forms;
  • Item No. 3: Items identical in all requirements compared with reviewed functional cosmetics and notified items, limited to cases where the functional ingredients and contents of a reviewed item (sun protection) and a notified item (whitening, wrinkle improvement) are mixed with each other.

Main Contents of This Revision

Based on the first version issued in 2022, this revision mainly adds the following two aspects:

  • Addition of an explanation of the circumstances where requirements confirmation is not approved: a dedicated chapter summarizes specific cases of requirements confirmation rejection, such as ineligible report submitters, omissions or errors in entries, and prohibited expressions in product names;
  • Addition of the reporting method for customized cosmetics: clarifying that multiple customized cosmetics product groups meeting the conditions may use the “multiple product name registration” function to report up to 10 products at one time.

Main Circumstances of Requirements Confirmation Rejection

The draft summarizes, in a dedicated chapter, the typical cases of requirements confirmation rejection, mainly including three categories:

1. Cases not falling within the scope of report submitters:

  • Filing a No. 1 report with a dosage form not listed in the KFCC (e.g., the reported item is a hydrogel but is filed as an impregnated mask preparation);
  • The dosage form of a No. 2 or No. 3 report differs from that of the reviewed item (e.g., the reported item is a cushion while the reviewed item is a cream);
  • The product name does not match the main ingredient (e.g., the reported item is named “retinol cream” while the main ingredient contains only adenosine);
  • The content of the main ingredient exceeds the notified limit.

2. Cases involving simple omissions and entry errors:

  • Wrong selection in the manufacturing/import field;
  • Inconsistency between the product name and the dosage form;
  • Inconsistency between the product name and the function;
  • Errors or omissions in the precautions for use;
  • Inconsistency between the main ingredient and the function;
  • Omission of the pH standard.

3. Cases where the product name contains prohibited expressions:

According to the Guidelines for Cosmetic Labeling and Advertising (Attached Table 1), product names must not contain prohibited expressions such as atopy, detox, antiviral, antibacterial, hair growth, skin regeneration, botulinum, needle , and filler.

Reporting Method for Customized Cosmetics

Customized cosmetics refer to cosmetics that are dispensed in required amounts from raw materials designated by MFDS, or mixed with other raw materials, at the point of sale by customized cosmetics blending managers according to consumers' preferences or skin types, and then sold. The system has been in effect since March 14, 2020.

Since multiple product names are often derived from the same formula, enterprises previously had to submit reports separately for each item. This revision clarifies that multiple customized cosmetics product groups in which all reporting items are identical — including types and contents of functional ingredients (including the amount of active substances), functions, methods of use and dosages, standards and test methods, precautions for use, and pH standard — may be reported at once by checking the “multiple product name registration” function, with up to 10 products registered at one time.

After adding product names, duplicate-name checks must be completed one by one, and none of them may duplicate an existing name. Operationally, only 1 report is generated at the temporary save stage; after the report is submitted, the system automatically generates 10 independent reports, which can be output and canceled separately.

For No. 2 and No. 3 reports, only 1 representative item in the product group needs to complete the ODM information provision request and obtain the manufacturer's confirmation in advance, which then covers all 10 items, significantly reducing the duplicate reporting burden for customized cosmetics.

Impacts and Recommendations for Relevant Enterprises

Review-exempt item reporting is one of the important pathways for functional cosmetics to enter the Korean market. Although this revision does not create new regulatory obligations, it further tightens the compliance standards for report preparation by supplementing the cases of requirements confirmation rejection and the reporting method for customized cosmetics. CIRS Group recommends that relevant enterprises:

  • Check the consistency of the product name, dosage form, functional claims, main ingredient content, precautions for use, and pH entries of the products to be reported against the newly added rejection cases in the draft, so as to avoid delays in launch arrangements caused by requirements confirmation rejection;
  • For enterprises exporting customized cosmetics to Korea, pay attention to the new operation method of “multiple product name registration, with up to 10 products reported at one time” and its impact on the reporting efficiency of product groups;
  • For those with submitted reports requiring modification, note that the cancellation procedure requires confirmation by the regional office, takes at least 4–5 days, and that a cancellation application cannot be canceled; arrange the product change schedule accordingly;
  • Follow the final release of the official version (the draft indicates that it is scheduled to be issued in November 2026), and adjust internal operating procedures based on the official text.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Our Services

  • South Korea Cosmetics Product Notification & Registration (General Cosmetics, Functional Cosmetics)
  • South Korea Cosmetic Ingredient Database (KCID) Registration
  • South Korea Responsible Party (RP) Services
  • South Korea Cosmetic Formula Review
  • South Korea Cosmetic Label Review
  • Quality Inspection

Further Information:

South Korea KCIA

GlobalCosing Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: GlobalCosing" on this website are copyrighted by GlobalCosing. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: GlobalCosing" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: GlobalCosing" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on GlobalCosing raises copyright or other related issues, please contact us within two weeks.

4. CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. GlobalCosing is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS’s current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.

Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
4.
CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. GlobalCosIng is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS's current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.